Arrowhead Pharmaceuticals, Inc. (ARWR)

Last Closing Price: 16.07 (2025-05-30)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Arrowhead Pharmaceuticals, Inc. (ARWR) had Net Income of $-599.49M for the most recently reported fiscal year, ending 2024-09-30.

Figures for fiscal year ending 2024-09-30
Income Statement Financials
$3.55M
Net Income
$-599.49M
--
$3.55M
$604.63M
$-601.08M
$-11.38M
$-612.46M
$-612.46M
$-609.69M
$-609.69M
$-609.69M
$-609.69M
$-601.08M
$-585.73M
119.78M
119.78M
$-5.00
$-5.00
Balance Sheet Financials
$695.47M
$386.03M
$444.33M
$1.14B
$103.17M
$393.18M
$845.57M
$948.74M
$191.06M
$182.50M
$191.06M
124.38M
Cash Flow Statement Financials
$-462.85M
$-420.07M
$870.52M
$110.89M
$102.69M
$-8.21M
$73.97M
--
--
Fundamental Metrics & Ratios
6.74
--
--
0.67
2.06
100.00%
-16927.06%
-16927.06%
-16494.76%
-17247.54%
-16882.37%
$-604.32M
--
--
--
0.00
--
--
--
-319.11%
-334.08%
-53.49%
-104.36%
$1.54
$-5.05
$-3.86